Black Diamond Therapeutics, Inc.
BDTX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $70.0M | $0K | |
| Operating income | $12.5M | −$78.8M | |
| Net income | $22.4M | −$69.7M |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 10, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $0K | $0K | |
| Operating income | −$12.1M | −$11.0M | −10.0% |
| Net income | −$10.0M | −$8.50M | −17.6% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Black Diamond's revenue in FY2025?
- $70.0M in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
- Was Black Diamond profitable in FY2025?
- Yes: net income was $22.4M and operating income $12.5M in FY2025.
- What was Black Diamond's revenue in Q3 2026?
- $0K (n/a vs a year earlier), per its Form 10-Q filed Nov 10, 2026.